Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06453902
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-05-28
Brief Title:
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia CML Patients
Sponsor:
Organization:
Shenzhen TargetRx Inc